Abstract
Purpose
Evaluate the impact of perennial allergic rhinitis (PAR) on the health-related quality of life (HRQL) and measure performance issues that are of major concerns for PAR patients, as well as determining the effect of intra-nasal steroids (INS) on PAR and associated congestion, sleep complaints, and daytime sleepiness.
Methods
This study was a cross-sectional study. A total of 78 PAR patients underwent otorhinolaryngological examination and skin test. All participants filled in the Nocturnal Rhinoconjunctivitis Quality of Life Questionnaire (NRQLQ), the Stanford Sleepiness Scale (SSS), and the Epworth Sleepiness Scale (ESS). Participants were asked to undergo treatment with Budesonide (BUD) topical aqueous nasal spray for eight weeks. After the treatment period, all participants were again asked to answer the three questionnaires.
Results
The results of this study found statistically significant improvements in the overall NRQLQ score (p < 0.001) and individual NRQLQ domain scores (p < 0.05) after INS treatment.
A statistically significant reduction in symptom severity in the four NRQLQ domains before and after treatment was found (p < 0.05), except for restlessness, post-nasal drip, and avoiding symptom triggers (p = 0.575, 0.172, and 0.705, respectively). There was a statistically significant difference in ESS and SSS scores before and after treatment (p < 0.001).
Conclusion
PAR has a significant impact on sleep quality and, as a result, a lower QOL. This study demonstrates that INS is an effective modality in the treatment of PAR and positively impacts patients' QOL by improving nasal symptoms, daytime fatigue, and somnolence, and sleep quality.
Similar content being viewed by others
Availability of data and material
The author confirms that the data supporting the findings of this study are available within the article.
Code availability
Not applicable.
References
Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, Van Weel C, Agache I (2008) Allergic rhinitis and its impact on asthma (ARIA). Allergy 63:8–160. https://doi.org/10.1111/j.1398-9995.2007.01620.x
Marple BF, Fornadley JA, Patel AA, Fineman SM, Fromer L, Krouse JH, Lanier BQ, Penna P, American Academy of Otolaryngic Allergy Working Group on Allergic Rhinitis (2007) Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction. Otolaryngol Head Neck Surg 136:S107-124. https://doi.org/10.1016/j.otohns.2007.02.031
Hughes K, Glass C, Ripchinski M, Gurevich F, Weaver TE, Lehman E, Fisher LH, Craig TJ (2003) Efficacy of the topical nasal steroid budesonide on improving sleep and daytime somnolence in patients with perennial allergic rhinitis. Allergy 58:380–385. https://doi.org/10.1034/j.1398-9995.2003.00093.x
Skoner DP (2001) Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol 108:2–8. https://doi.org/10.1067/mai.2001.115569
Shedden A (2005) Impact of nasal congestion on quality of life and work productivity in allergic rhinitis. Treat Respir Med 4:439–446. https://doi.org/10.2165/00151829-200504060-00007
Juniper EF, Rohrbaugh T, Meltzer EO (2003) A questionnaire to measure quality of life in adults with nocturnal allergic rhinoconjunctivitis. J Allergy Clin Immun 111:484–490. https://doi.org/10.1067/mai.2003.137
Reinberg A, Gervais P, Levi F, Smolensky M, Del Cerro L, Ugolini C (1988) Circadian and circannual rhythms of allergic rhinitis: an epidemiologic study involving chronobiolologic methods. J Allergy Clin Immunol 81:51–62. https://doi.org/10.1016/0091-6749(88)90220-5
Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B (1994) Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 94:182–188. https://doi.org/10.1053/ai.1994.v94.a54939
Cottle MH (1972) Nasal breathing pressures and cardio-pulmonary illness. Ear Nose Throat J 51:331–340
Millman RP, Acebo C, Rosenberg C, Carskadon MA (1996) Sleep, breathing, and cephalometrics in older children and young adults: Part II– Response to nasal occlusion. Chest 109:673–679. https://doi.org/10.1378/chest.109.3.673
Young T, Finn L, Kim H (1997) Nasal obstruction as a risk factor for sleep disordered breathing. J Allergy Clin Immunol 99:757–762. https://doi.org/10.1016/S0091-6749(97)70124-6
McNicholas WT, Tarlo S, Cole P, Zamel N, Rutherford R, Griffin D, Phillipson EA (1982) Obstructive apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis 126:625–628. https://doi.org/10.1164/arrd.1982.126.4.625
Linden M, Svensson C, Andersson E, Andersson M, Greiff L, Persson CG (2000) Immediate effect of topical budesonide on allergen challenge-induced nasal mucosal fluid levels of granulocytemacrophage colony-stimulating factor and interleukin-5. Am J Respir Crit Care Med 162:1705–1708. https://doi.org/10.1164/ajrccm.162.5.9910094
Craig TJ, Teets S, Lehman EB, Chinchilli VM, Zwillich C (1998) Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response of topical nasal steroids. J Allergy Clin Immunol 101:633–637. https://doi.org/10.1016/S0091-6749(98)70171-X
Annesi-Maesano I, Didier A, Klossek M, Chanal I, Moreau D, Bousquet J (2002) The score for allergic rhinitis (SFAR): a simple and valid assessment method in population studies. Allergy 57:107–114. https://doi.org/10.1034/j.1398-9995.2002.1o3170.x
Hoddes E (1971) The history and use of the Stanford Sleepiness Scale. Psychophysiology 9:150
Johns MW (1992) Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep 15:376–381. https://doi.org/10.1093/sleep/15.4.376
Meltzer EO, Blaiss MS, Derebery MJ, Mahr TA, Gordon BR, Sheth KK, Simmons AL, Wingertzahn MA, Boyle JM (2009) Burden of allergic rhinitis: results from the Pediatric Allergies in America survey. J Allergy Clin Immunol 124:43–70. https://doi.org/10.1016/j.jaci.2009.05.013
Soose RJ (2011) Role of allergy in sleep-disordered breathing. Otolaryngol Clin N Am 44:625–635. https://doi.org/10.1016/j.otc.2011.03.020
Williams AJ, Santiago SM (1993) The nose and obstructive sleep apnea. Chest 104:993. https://doi.org/10.1378/chest.104.4.993a
Papsidero MJ (1993) The role of nasal obstruction in obstructive sleep apnea syndrome. Ear Nose Throat J 72:82–84. https://doi.org/10.1177/014556139307200118
Berry RB, Gleeson K (1997) Respiratory arousal from sleep: mechanisms and significance. Sleep 20:654–675. https://doi.org/10.1093/sleep/20.8.654
Mikhail E, Azizoglu S, Gokhale M, Suphioglu C (2020) Questionnaires assessing the quality of life of ocular allergy patients. J Allergy Clin Immunol Pract 8:2945–2952. https://doi.org/10.1016/j.jaip.2020.04.023
Mintz M, Garcia J, Diener P, Liao Y, Dupclay L, Georges G (2004) Triamcinolone acetonide aqueous nasal spray improves nocturnal rhinitis-related quality of life in patients treated in a primary care setting: the Quality of Sleep in Allergic Rhinitis study. Ann Allergy Asthma Immunol 92:255–261. https://doi.org/10.1016/S1081-1206(10)61557-8
Léger D, Annesi-Maesano I, Carat F, Rugina M, Chanal I, Pribil C, El Hasnaoui A, Bousquet J (2006) Allergic rhinitis and its consequences on quality of sleep: an unexplored area. Arch Intern Med 166:1744–1748. https://doi.org/10.1001/archinte.166.16.1744
Craig TJ, Sherkat A, Safaee S (2010) Congestion and sleep impairment in allergic rhinitis. Curr Allergy Asthma Rep 10:113–121
Yamada T, Yamamoto H, Kubo S, Sakashita M, Tokunaga T, Susuki D, Fujieda S (2012) Efficacy of mometasone furoate nasal spray for nasal symptoms, quality of life, rhinitis-disturbed sleep, and nasal nitric oxide in patients with perennial allergic rhinitis. Allergy Asthma Proc. https://doi.org/10.2500/aap.2012.33.3509
Craig TJ, Mende C, Hughes K, Kakumanu S, Lehman EB, Chinchilli V (2003) The effect of topical nasal fluticasone on objective sleep testing and the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis. Allergy Asthma Proc 24:53
Meltzer EO, Munafo DA, Chung W, Gopalan G (2010) Varghese ST (2010) Intranasal mometasone furoate therapy for allergic rhinitis symptoms and rhinitis-disturbe dsleep. Ann Allergy Asthma Immunol 105:65–74. https://doi.org/10.1016/j.anai.2010.04.020
Gunhan K, Unlu H, Yuceturk AV, Songu M (2011) Intranasal steroids or radiofrequency turbinoplasty in persistent allergic rhinitis: effects on quality of life and objective parameters. Eur Arch Otorhinolaryngol 268:845–850
Jordana G, Dolovich J, Briscoe MP, Day JH, Drovin MA, Gold M, Robson R, Yang SN, W, (1996) Intranasal fluticasone propionate versus loratadine in the treatment of adolescent patients with seasonal allergic rhinitis. J Allergy Clin Immunol 97:588–595. https://doi.org/10.1016/S0091-6749(96)70303-2
Meltzer EO (2004) Introduction: Stuffy is also related to Sleepy and Grumpy–the link between rhinitis and sleep-disordered breathing. J Allergy Clin Immunol 114:133–134
Acknowledgment
The author thanks all the patients who took part in this work for their help.
Funding
The author has no funding or financial relationships to disclose.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author has no conflicts of interest to report.
Ethics approval
All ethical considerations were completed before the study. Ethical approval from the Medical University Research Center has been requested (IRB No. 20–0552).
Consent to participate
Informed consent was obtained prior to the start of the study. Thus, the participants were informed about the objectives of the study and the steps in carrying it out, as well as about its risks and benefits.
Consent for publication
The publication is approved by the author, and that, if accepted, it will not be published elsewhere in the same form.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Abdelhafeez, M. Effectiveness of intranasal steroids on rhinitis symptoms, sleep quality, and quality of life in patients with perennial allergic rhinitis. Eur Arch Otorhinolaryngol 279, 249–256 (2022). https://doi.org/10.1007/s00405-021-06818-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-021-06818-1